Detecting multiple sepsis biomarkers from whole blood - made fast, accurate, and cheap

A multi-disciplinary team at Harvard's Wyss Institute for Biologically Inspired Engineering and the University of Bath, UK, has further developed the Institute's eRapid technology as an affinity-based, low-cost electrochemical diagnostic sensor platform for the multiplexed detection of clinically relevant biomarkers in whole blood. The device uses a novel graphene nanocomposite-based surface coating and was demonstrated to accurately detect three different sepsis biomarkers simultaneously.